- SCNX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Scienture (SCNX) CORRESPCorrespondence with SEC
Filed: 30 Nov 22, 12:00am
November 30, 2022
VIA EDGAR
Division of Corporate Finance
U.S. Securities and Exchange Commission
Office of Trade & Services
100 F Street, N.E.
Washington D.C. 20549
Re: | TRxADE HEALTH, INC. |
Form S-1 Registration Statement
Filed November 28, 2022
File No. 333-268574
Acceleration Request
Request Date: Friday, December 2, 2022
Request Time: 4:00 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, TRxADE HEALTH, INC. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-captioned Registration Statement (the “Registration Statement”) to become effective on Friday, December 2, 2022, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
The Registrant hereby authorizes David M. Loev and/or John S. Gillies of The Loev Law Firm, PC, to orally modify or withdraw this request for acceleration. Please contact Mr. Loev at (832) 930-6432, with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Sincerely, | |
/s/ Suren Ajjarapu | |
Suren Ajjarapu | |
Chief Executive Officer |